降糖药-话题@MedSci

#降糖药#

178篇内容 | 4805人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1270880, encodeId=661512e088037, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者降糖药物相关的糖尿病视网膜病变事件比较！, objectType=article, longId=127918, objectId=d1ad12e91858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1ad12e91858, replyNumber=0, likeNumber=64, createdTime=2018-01-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1ad12e91858, moduleTitle=Diabetes Obes Metab：2型糖尿病患者降糖药物相关的糖尿病视网膜病变事件比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1ad12e91858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270879, encodeId=fcd412e0879b7, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=病例：正确使用降糖药其实大有学问！, objectType=article, longId=127582, objectId=4cbe12e5828b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cbe12e5828b, replyNumber=0, likeNumber=67, createdTime=2018-01-26, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cbe12e5828b, moduleTitle=病例：正确使用降糖药其实大有学问！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cbe12e5828b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270878, encodeId=a20112e087854, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=病例分享：胃肠道反应是影响口服降糖药物选择的重要因素, objectType=article, longId=127358, objectId=b10e12e35811, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b10e12e35811, replyNumber=0, likeNumber=78, createdTime=2018-01-24, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b10e12e35811, moduleTitle=病例分享：胃肠道反应是影响口服降糖药物选择的重要因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b10e12e35811)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270941, encodeId=114e12e09417e, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=降糖药，你吃对了吗？, objectType=article, longId=126396, objectId=a2d4126396f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d4126396f3, replyNumber=0, likeNumber=154, createdTime=2018-01-14, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d4126396f3, moduleTitle=降糖药，你吃对了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d4126396f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270877, encodeId=d1e212e0877f3, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星, objectType=article, longId=125868, objectId=eb8e12586871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb8e12586871, replyNumber=0, likeNumber=71, createdTime=2018-01-09, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb8e12586871, moduleTitle=Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb8e12586871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270876, encodeId=17b212e0876b3, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=中国一周一次降糖药百达扬获批, objectType=article, longId=125693, objectId=8318125693c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8318125693c5, replyNumber=0, likeNumber=79, createdTime=2018-01-07, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8318125693c5, moduleTitle=中国一周一次降糖药百达扬获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8318125693c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270875, encodeId=d41b12e08755c, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Int J Cardiol：新型降糖药物的心血管预后分析！, objectType=article, longId=124174, objectId=ad691241e4ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad691241e4ca, replyNumber=0, likeNumber=62, createdTime=2017-12-23, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad691241e4ca, moduleTitle=Int J Cardiol：新型降糖药物的心血管预后分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad691241e4ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270874, encodeId=43e712e087418, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes, Obes Metab：研究发现三分之一的糖尿病患者未遵医嘱服用降糖药！, objectType=article, longId=123866, objectId=315f123866ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=315f123866ca, replyNumber=0, likeNumber=58, createdTime=2017-12-20, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=315f123866ca, moduleTitle=Diabetes, Obes Metab：研究发现三分之一的糖尿病患者未遵医嘱服用降糖药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=315f123866ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270873, encodeId=782812e087386, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=美国糖尿病协会更新指南：热推有明确心血管获益的降糖药, objectType=article, longId=123174, objectId=c8331231e425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8331231e425, replyNumber=0, likeNumber=70, createdTime=2017-12-14, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8331231e425, moduleTitle=美国糖尿病协会更新指南：热推有明确心血管获益的降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8331231e425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270872, encodeId=1dc212e08725a, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=新型降糖药恩格列净：打破2型糖尿病合并心血管疾病临床治疗僵局, objectType=article, longId=122805, objectId=9e8812280541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8812280541, replyNumber=0, likeNumber=68, createdTime=2017-12-10, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8812280541, moduleTitle=新型降糖药恩格列净：打破2型糖尿病合并心血管疾病临床治疗僵局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8812280541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270871, encodeId=58fd12e0871ad, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Stroke：降糖药与颅内动脉瘤破裂呈负相关！, objectType=article, longId=122424, objectId=c311122424ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c311122424ea, replyNumber=0, likeNumber=88, createdTime=2017-12-07, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c311122424ea, moduleTitle=Stroke：降糖药与颅内动脉瘤破裂呈负相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c311122424ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270870, encodeId=a56212e0870db, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病：口服降糖药中加入Gla-100 哪些因素影响临床结局？, objectType=article, longId=121710, objectId=d047121e1067, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d047121e1067, replyNumber=0, likeNumber=77, createdTime=2017-11-30, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d047121e1067, moduleTitle=Diabetes Obes Metab：2型糖尿病：口服降糖药中加入Gla-100 哪些因素影响临床结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d047121e1067)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270869, encodeId=ac0a12e086992, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Care：近年来二甲双胍使用率持续攀升，二线降糖药将“何去何从”？, objectType=article, longId=120723, objectId=c582120e23a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c582120e23a0, replyNumber=0, likeNumber=84, createdTime=2017-11-21, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c582120e23a0, moduleTitle=Diabetes Care：近年来二甲双胍使用率持续攀升，二线降糖药将“何去何从”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c582120e23a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270868, encodeId=4b6112e0868df, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Eur J Prev Cardiol：2型糖尿病患者或许更适合具有CV益处的降糖药物, objectType=article, longId=120389, objectId=2e681203899b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e681203899b, replyNumber=0, likeNumber=63, createdTime=2017-11-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e681203899b, moduleTitle=Eur J Prev Cardiol：2型糖尿病患者或许更适合具有CV益处的降糖药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e681203899b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270867, encodeId=403412e0867c0, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Diabetes Obes Metab：降糖药信得过吗？强化血糖控制可能使你面临什么风险？, objectType=article, longId=120361, objectId=3f53120361ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f53120361ca, replyNumber=0, likeNumber=82, createdTime=2017-11-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f53120361ca, moduleTitle=Diabetes Obes Metab：降糖药信得过吗？强化血糖控制可能使你面临什么风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f53120361ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270866, encodeId=40de12e086654, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=《细胞》：振奋人心！科学家发现新型降糖药，无促进脂肪生成副作用，神药二甲双胍的地位或将受到挑战 | 科学大发现, objectType=article, longId=118467, objectId=cf0211846ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0211846ecd, replyNumber=0, likeNumber=47, createdTime=2017-11-03, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0211846ecd, moduleTitle=《细胞》：振奋人心！科学家发现新型降糖药，无促进脂肪生成副作用，神药二甲双胍的地位或将受到挑战 | 科学大发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0211846ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270865, encodeId=7a2f12e0865d3, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=2017 KDA立场声明：降糖药物治疗成人2型糖尿病, objectType=article, longId=118215, objectId=28e91182155d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28e91182155d, replyNumber=0, likeNumber=32, createdTime=2017-11-01, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28e91182155d, moduleTitle=2017 KDA立场声明：降糖药物治疗成人2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28e91182155d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270864, encodeId=2af612e0864ca, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Cell Metab：两周减重25%，德国科学家巧妙结合降糖药与抗炎药，制成靶向减肥「神药」 | 科学大发现, objectType=article, longId=115891, objectId=602d11589151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=602d11589151, replyNumber=0, likeNumber=125, createdTime=2017-10-13, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=602d11589151, moduleTitle=Cell Metab：两周减重25%，德国科学家巧妙结合降糖药与抗炎药，制成靶向减肥「神药」 | 科学大发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=602d11589151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270863, encodeId=c33e12e0863e7, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险, objectType=article, longId=115490, objectId=c0a811549083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a811549083, replyNumber=0, likeNumber=62, createdTime=2017-10-11, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a811549083, moduleTitle=Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0a811549083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1270862, encodeId=1f0012e0862bd, content=<a href='/topic/show?id=4066981e99e' target=_blank style='color:#2F92EE;'>#降糖药#</a>, objectTitle=新型降糖药物是如何发挥心血管保护作用的？, objectType=article, longId=115173, objectId=54461151e312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54461151e312, replyNumber=0, likeNumber=90, createdTime=2017-10-05, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54461151e312, moduleTitle=新型降糖药物是如何发挥心血管保护作用的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54461151e312)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

降糖药

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Obes Metab：2型糖尿病患者降糖药物相关的糖尿病视网膜病变事件比较！

2018-01-28

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

病例：正确使用降糖药其实大有学问！

2018-01-26

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

病例分享：胃肠道反应是影响口服降糖药物选择的重要因素

2018-01-24

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

降糖药，你吃对了吗？

2018-01-14

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes：经典降糖药DPP-4抑制剂竟然还是糖尿病足的克星

2018-01-09

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

中国一周一次降糖药百达扬获批

2018-01-07

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Int J Cardiol：新型降糖药物的心血管预后分析！

2017-12-23

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes, Obes Metab：研究发现三分之一的糖尿病患者未遵医嘱服用降糖药！

2017-12-20

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

美国糖尿病协会更新指南：热推有明确心血管获益的降糖药

2017-12-14

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

新型降糖药恩格列净：打破2型糖尿病合并心血管疾病临床治疗僵局

2017-12-10

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Stroke：降糖药与颅内动脉瘤破裂呈负相关！

2017-12-07

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Obes Metab：2型糖尿病：口服降糖药中加入Gla-100 哪些因素影响临床结局？

2017-11-30

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Care：近年来二甲双胍使用率持续攀升，二线降糖药将“何去何从”？

2017-11-21

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Eur J Prev Cardiol：2型糖尿病患者或许更适合具有CV益处的降糖药物

2017-11-18

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Diabetes Obes Metab：降糖药信得过吗？强化血糖控制可能使你面临什么风险？

2017-11-18

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

《细胞》：振奋人心！科学家发现新型降糖药，无促进脂肪生成副作用，神药二甲双胍的地位或将受到挑战 | 科学大发现

2017-11-03

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

2017 KDA立场声明：降糖药物治疗成人2型糖尿病

2017-11-01

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Cell Metab：两周减重25%，德国科学家巧妙结合降糖药与抗炎药，制成靶向减肥「神药」 | 科学大发现

2017-10-13

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险

2017-10-11

minlingfeng (审核中...)

前往app查看评论内容

#降糖药#

新型降糖药物是如何发挥心血管保护作用的？

2017-10-05

科室
- - 订阅+
  - 更多科室
工具
服务